An adhesive gel packed with light-activated chemicals can seal cuts or ulcers on the cornea —the clear surface of the eye — and then encourage the regeneration of corneal tissue, according to a preclinical study published online today in Science Advances. The new technology, named GelCORE (gel for corneal regeneration), could one day reduce the need for surgery to repair injuries to the cornea, including those that would today require corneal transplantation.
“Our hope is that this biomaterial could fill in a major gap in technology available to treat corneal injuries,” said co-corresponding author Reza Dana, MD, Director of the Cornea and Refractive Surgery Service at Massachusetts Eye and Ear and the Claes H. Dohlman Professor of Ophthalmology at Harvard Medical School. “We set out to create a material that is clear, strongly adhesive, and permits the cornea to not only close the defect, but also to regenerate. We wanted this material to allow the cells of the cornea to mesh with the adhesive and to regenerate over time to mimic something as close to the native cornea as possible.”
Corneal injuries are a common cause of visual impairment worldwide, with more than 1.5 million new cases of corneal blindness reported every year. The current standard of care for filling in cuts, thinning areas, or holes in the cornea (corneal defects) includes the use of synthetic glues or surgery to patch the eye with tissue and/or corneal transplants. The synthetic glues currently available are rough, inherently toxic to tissues, difficult to handle, and can lead to significant vision loss due to the material’s opacity and poor integration with corneal tissues. Corneal transplants carry risks of post-transplant complications, including infection or rejection.
With the goal of addressing this unmet clinical need, researchers on the Science Advances report set out to develop an adhesive designed for long-term integration with the cornea.
The team engineered an adhesive biomaterial, GelCORE, made of chemically modified gelatin and photoinitiators, which are activated by a short-time exposure to blue light. Initially, the gel is a clear, viscous material designed to be applied with a dropper or syringe. When exposed to light, the material hardens, taking on the biomechanical features of a native cornea. And, over time, the cornea cells gradually grow into and become one with this material. Thus, GelCORE is similar to the native cornea — highly transparent, able to bond to the native tissue, and capable of supporting cell and tissue regeneration.
Similar adhesive technologies have been designed for lung and other eye defects, but GelCORE is the first to use visible blue light as opposed to ultraviolet light, which carries a level of toxicity that blue light does not.
In the Science Advances report, the researchers describe their assessments of GelCORE in a preclinical model of corneal injury. They applied GelCORE at 20 percent concentration to corneal defects of 3mm, and then applied visible light for 4 minutes. Immediately after the light exposure, they observed firm adhesion of the gel to the corneal defect. One day later, they observed a transparent, smooth eye surface, with a surrounding cornea that was clear and without inflammation. One week after application, the gel could still be observed on the defect site in the cornea and remained transparent. Over time, the tissue showed signs of regeneration, with cells of the new tissue showing similarities between regenerated tissue and native tissue.
The study authors also note that the properties of GelCORE can be finely controlled by varying the concentration and the amount of time exposed to light — offering the possibility of changing the formulation for different types and severities of eye injuries. “We’re now looking to make certain modifications for different applications,” Dr. Dana said. “We envision, if a patient comes in with a big laceration, they might receive formulation A. If they come in with a corneal scar, they might get formulation B.” The authors also hope to begin clinical trials to test the technology in human patients in approximately one year.
The Latest on: Biomaterial
via Google News
The Latest on: Biomaterial
- Researchers 3D print first human heart with patient’s own biomaterial on April 16, 2019 at 7:47 am
Researchers from Tel Aviv University have made a significant breakthrough in medicine. The team has successfully 3D printed the world’s first 3D vascularized heart using the patient’s cells and ... […]
- Nvision’s foot and ankle implant cleared by the FDA on April 16, 2019 at 6:41 am
The implant is made from the advanced, biocompatible polymer PEEK-OPTIMA HA Enhanced from Invibio Biomaterial Solutions. It is the first foot and ankle implant to be made from this material, aswell as ... […]
- Postcard from Zaharah: Letting an idea go to the head on April 13, 2019 at 11:22 pm
The 45-year-old researcher who did biomaterial implanted into eyes and heart sensors, to name a few, literally allowed her ideas to go to the head and now as founder of Instant Hijabs UK, she is proud ... […]
- Sticky biomaterial could repair corneal injuries in patients on April 8, 2019 at 10:59 pm
Vision loss is a serious and common symptom of corneal injuries, with more than 1.5 million cases of corneal blindness reported every year. Corneal injuries typically result from a trauma or an ... […]
- Korean Research Team Develops Methanol-Producing Biomaterial with High Efficiency on April 2, 2019 at 7:43 pm
A Korea University research team has developed a biomaterial that can produce methanol from methane. A Korean research team has developed a biomaterial that can produce methanol from methane, which is ... […]
- Need a new ear? Technion opens 3D tissue printer for researchers on April 1, 2019 at 3:12 am
A 3D center for the printing of cells, tissues and organs has been set up in the Technion–Israel Institute of Technology in Haifa to enable researchers to print complex tissues and improve their ... […]
- Orthopedic Biomaterial Market Worldwide Analysis 2019 with 3M ESPE, Materion Corporation, Nobel Biocare Services AG, etc | Forecast to 2023 on March 25, 2019 at 3:47 am
Universal Orthopedic Biomaterial Market analytical surveying Report is added on Marketresearchfuture.com with 105 pages. A separate section with Orthopedic Biomaterial industry key players is included ... […]
- India- Orthopedic Biomaterial Industry Analysis by Size, Revenue, Growth Factors, Region Wise Analysis, Segments, Top 10 Players and Forecast to 2023 on March 20, 2019 at 2:00 am
The orthopedic biomaterial market is growing pervasively, witnessing an exponential growth backed by the increasing investments in the R & D activities. Healthcare segment extensively absorbs ... […]
- Hydromer Inc. Expands its Team to Address the Growing Demand in the Biomaterial Coatings Market for Medical Devices on February 19, 2019 at 2:33 pm
Branchburg, NJ, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hydromer, Inc. (OTC Pink: HYDI) announces today that Mr. Matt J. McGlon has joined the Hydromer team in the capacity of National ... […]
- Metal Orthopaedic Biomaterial Market 2019-2026 Analysis by Top Players: Acumed, Medtronic PLC, Globus Medical, Stryker Corporation, Exactech Inc. on February 18, 2019 at 10:37 pm
A closer look at the overall Metal Orthopaedic Biomaterial business scenario presented through self-explanatory charts, tables, and graphics images add greater value to the study. This press release ... […]
via Bing News